NF1 and neoplasm: Previous works focused on the risk of OPG in NF1 patients and reported conflicting results on the association between tumor development and mutation position, with some studies reporting an increased risk of OPG in patients harboring mutations in the 5′tertile of NF1 (exons 1–21) [47,48], while others not confirming this finding [49].